WWM
IMGN

Wolff Wiese Magana’s Immunogen Inc IMGN Stock Holding History

Wolff Wiese Magana’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,825
Closed -$9K – 1001
2022
Q3 		$9K Hold
1,825
– – 0.01% 526
2022
Q2 		$8K Hold
1,825
– – 0.01% 574
2022
Q1 		$9K Hold
1,825
– – 0.01% 557
2021
Q4 		$14K Hold
1,825
– – 0.01% 494
2021
Q3 		$10K Hold
1,825
– – 0.01% 527
2021
Q2 		$12K Sell
1,825
-3
-0.2% -$21 0.01% 477
2021
Q1 		$15K Hold
1,828
– – 0.01% 431
2020
Q4 		$12K Buy
+1,828
New +$10.7K 0.01% 430

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wolff Wiese Magana's IMGN Position: Q4 2022 in Review

Wolff Wiese Magana sold out of Immunogen Inc (IMGN) in Q4 2022, closing a stake of 1,825 shares — an estimated $9K sold.

Wolff Wiese Magana first reported a position in IMGN in Q4 2020 and held it in 8 quarters. The position peaked at $15K in Q1 2021. 204 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.

  • Wolff Wiese Magana reported no remaining Immunogen Inc position as of Q4 2022 after selling out during the quarter.
  • Wolff Wiese Magana sold 1,825 Immunogen Inc shares in Q4 2022, an estimated $9K.
  • Wolff Wiese Magana first reported a position in Immunogen Inc in Q4 2020 and held it in 8 quarters.
  • Wolff Wiese Magana's Immunogen Inc position peaked at $15K in Q1 2021.
  • 204 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.

Based on Wolff Wiese Magana's 13F filing for Q4 2022, filed 9 Feb 2023.